Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 141-150 of 290 for

Edit search filters
  1. Study of TJ011133 in Participants With Relapsed/ Refractory Advanced Solid Tumors and Lymphoma

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  2. Maintenance Chemotherapy With or Without Stereotactic Body Radiation Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  3. VX15/2503 in Combination With Avelumab in Advanced Non-small Cell Lung Cancer

    Jacksonville, FL, Rochester, MN

  4. Study of TH-302 or Placebo in Combination With Pemetrexed in Patients With Non-squamous Non-small Cell Lung Cancer

    Rochester, MN

  5. A Study to Evaluate Biomarker/ALK Inhibitor Combinations in Treating Patients With Stage IV ALK Positive Non-squamous Non-small Cell Lung Cancer (The NCI-NRG ALK Protocol)

    Rochester, MN

  6. MEDI5395 Advanced Solid Tumors

    Scottsdale/Phoenix, AZ, Rochester, MN

  7. PF-07284892 in Participants With Advanced Solid Tumors

    Scottsdale/Phoenix, AZ, Rochester, MN

  8. Safety Study of Enoblituzumab (MGA271) in Combination With Pembrolizumab in Refractory Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  9. Corticosteroids + Bevacizumab vs. Corticosteroids + Placebo (BEST) for Radiation Injury After Treatment for Brain Metastases

    Rochester, MN

  10. Study of Nivolumab Combined With Ipilimumab Versus Pemetrexed and Cisplatin or Carboplatin as First Line Therapy in Unresectable Pleural Mesothelioma Patients

    Rochester, MN

.

Mayo Clinic Footer